Pharma Law USA
Benjamin Fuller of Cornerstone Research will discuss the 340B drug program at this conference hosted by Informa Connect in Boston.
Hatching a Procompetitive Settlement
Celeste Saravia of Cornerstone Research will join attorneys and a regulator at this webinar hosted by the Section of Antitrust Law of the American Bar Association.
Tevra Brands LLC v. Bayer Healthcare LLC
A jury awarded the defendant a complete victory at trial in this antitrust litigation involving allegations of anticompetitive exclusive dealing in the market for flea and tick medications.
Our Curious Amalgam: How Do We Measure Innovation?
In an American Bar Association podcast, Penka Kovacheva of Cornerstone Research discussed how M&A affects innovation in the pharmaceutical industry.
The Impact of Pharmaceutical M&A on Innovation
The authors examine existing academic literature on the impact of pharmaceutical mergers and acquisitions and identify remaining gaps.
ASHEcon 2024: The Annual Conference of the American Society of Health Economists
Cornerstone Research staff and affiliated experts will speak at this annual conference hosted by the American Society of Health Economics.
2024 Antitrust in Healthcare
Anup Malani of the University of Chicago and James Lee of Cornerstone Research will discuss competition issues in healthcare and life sciences at this American Bar Association conference.
Entrenching and Leveraging Market Dominance in the 2023 Merger Guidelines: Insights from Amgen/Horizon
Insights from Amgen/Horizon merger on leveraging market dominance via bundling under 2023 Merger Guidelines.
How A 3-Firm ‘Joint Effort’ Beat A $3.6B Pharma Antitrust Suit
In this Law360 article, counsel discusses Celeste Saravia’s pivotal role as the economic expert in a pharmaceutical antitrust lawsuit.
Ciccio et al. v. SmileDirectClub LLC et al.
Class certification was denied in this false advertising matter.
How can we help you?
If you are looking for a publication not on our website, contact us.